U.S. court orders Takeda to pay $6 billion

TOKYO, Japan - File photo taken in October 2010 shows the Tokyo headquarters of Takeda Pharmaceutical Co. The company said Sept. 4, 2014, it has been ordered by a U.S. district court to pay $6 billion in punitive damages over a lawsuit filed by a man who claimed his bladder cancer was caused by Takeda's diabetes medicine Actos. Takeda plans to counter the move through legal means, including the option of appealing to a higher court, company officials said.